Peninsula Health Heart Service is proud to present Healthy Hearts GP Education Series 2017 - Meeting 2 Spotlight on Acute.

Slides:

Advertisements

Similar presentations

PRIMIS Third National Conference Tuesday 1 April 2003 Birmingham HIP for CHD Jane Matthews Practice Nurse Dr. Dai Evans PRIMIS Regional Clinical Adviser.

Advertisements

National Service Frameworks Dr Stephen Newell February 2002.

THE ROLE OF THE CARDIAC NURSE PRACTITIONER

Ischaemic Heart Disease- Implications of Gender Dr Kaye Birks School of Rural Health Monash University Australia Gender Competency Training for Medical.

ISCHAEMIC HEART DISEASE Acute Coronary Syndromes JD Marx Department of Cardiology University of the Free State.

Trial profile Fox K et al. Lancet 2008;372:

British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.

Ischaemic Heart Disease for the GP Chris Tracey GPVTS.

West Hertfordshire NHS Trust

Diabetes Trials Unit University of Oxford WebSite: Lipids in Diabetes Study.

Update on the Medical Management of Acute Coronary Syndrome.

Management of Stable Angina SIGN 96

SCAAR UCR SWEDEN 2007 Stefan James, Jörg Carlsson, Johan Lindbäck, Tage Nilsson, Ulf Stenestrand, Lars Wallentin and Bo Lagerqvist for the SCAAR study.

Live Active / Vitality Introduction Lianne Thomas.

Quality Improvement Initiatives. National Service Framework for Coronary Heart Disease-UK Cooperative Cardiovascular Project (CCP)-USA National Registry.

ANGINA IS CHEST PAIN OR DISCOMFORT THAT HAPPENS WHEN AN AREA OF YOUR HEART MUSCLE DOESN'T GET ENOUGH OXYGEN-RICH BLOOD.

Prospective, Randomized Evaluation of Immediate Versus Deferred Angioplasty in Patients with High Risk Acute Coronary Syndromes RK Riezebos 1, E Ronner.

Professor Martin T Rothman Director Cardiac Research & Development Barts & The London NHS Trust London, England Professor Martin T Rothman Director Cardiac.

TARGET and TACTICS Clinical Trial Commentary Dr Eric Topol Chairman and Professor, Department of Cardiology Director of the Joseph J Jacobs Center for.

MENU ΣΤΕΦΑΝΙΑΙΑ ΝΟΣΟΣ ΣΕ ΔΙΑΒΗΤΙΚΟΥΣ ΚΑΙ ΗΛΙΚΙΩΜΕΝΟΥΣ.

Acute Coronary Syndromes in West Hertfordshire Masood Khan.

Coronary Revascularisation: the DoH View Dr Roger Boyle National Director for Heart Disease.

Coronary Heart Disease (CHD) László Tornóci Inst. Pathophysiology Semmelweis University.

Can we better protect patients who undergo revascularization? Beneficial effects of short- and long-term trimetazidine MR therapy in patients undergoing.

Perindopril Remodeling in Elderly with Acute Myocardial Infarction PREAMIPREAMI Presented at The European Society of Cardiology Hot Line Session, September.

Ischemia Management with Accupril Post Bypass Graft via Inhibition of Angiotensin Converting Enzyme IMAGINEIMAGINE Presented at The European Society of.

Issued in 2014 – SCAAR. SCAAR Annual report 2013.

Issued in 2015 – SCAAR. SCAAR Annual report 2014.

Comparison of drug-eluting stents in real-life clinical practice in Sweden: Insights from the SCAAR register. Goran K. Olivecrona 1, Elvin Kedhi 2, Elmir.

Consistency in diagnostic and treatment procedures Specifically angiography and angioplasty Dr Alison Round 14 October 2015.

Associate Professor, Honorary Consultant Cardiologist

Prof. Dr. med. Sigmund Silber Cardiology Practice and Hospital

Latvian Centre of Cardiology real-life registry

(CCTA, computed coronary tomography angiography; CMR, cardiac magnetic resonance; ECG, electrocardiogram; Echo, echocardiography; IHD, ischemic heart disease;

Coronary stent immobilisation with rapid ventricular pacing technique via coronary guidewire in non-ST elevation myocardial infarction Dr Zaid Iskandar.

Specialist Cardiologist at Sydney. Macquarie University Hospital Cardiology at Macquarie University Hospital, a team of specialist cardiologist, who diagnose.

Figure 1 Ischaemic endpoints

Primary Care Stratified Follow-up of Stable Prostate Cancer Patients

Salisbury Walk in Health Centre

College of Nursing ● University of Kentucky ● Lexington, KY

Cardiology Health Talk

Copyright © 2009 American Medical Association. All rights reserved.

RISK STRATIFICATION TOOL

The Ottawa Hospital Pathway For Early Intervention In Rib Fracture

R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R

Glenn N. Levine et al. JACC 2016;68:

Western Norway B-vitamin Intervention Trial

GP Education Session – July 2018 Suicide Prevention – Dr Mike Tervit Clinical Director Mental Health & ATODS CHHHS updates presented by Associate Professor.

Terms of Use. Terms of Use.

Forced Marriage Workshop

Shared Maternity Care Program Education Forum

ANTARCTIC Trial design: Patients with acute coronary syndrome undergoing stenting were randomized to tailored antiplatelet therapy (n = 435) versus conventional.

SIGNIFY Trial design: Participants with stable coronary artery disease without clinical heart failure and resting heart rate >70 bpm were randomized to.

FAMOUS-NSTEMI Trial design: Participants with NSTEMI were randomized to an FFR-guided strategy (n = 176) vs. a coronary angiography-guided strategy (n.

Invasive versus conservative treatment in unstable coronary syndromes

TRIAL HIGHLIGHT FROM ESC 2016: ACUTE CORONARY SYNDROMES

Cognitive-behaviourAL therapy (CBT) for Social Anxiety

FOURIER Trial design: Patients with established cardiovascular disease on statin therapy were randomized to evolocumab 140 mg subcutaneous every 2 weeks.

Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.

Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Toshihiro Fukui,

ARISE Trial Aggressive Reduction of Inflammation Stops Events

Flow Diagram of the Trial Selection Process

Early and locally advanced breast cancer

Advantages of an early invasive approach in acute coronary syndromes

Lee A. Fleisher et al. JACC 2014;64:e77-e137

Antithrombotic strategies in patients on long-term oral anticoagulation therapy undergoing percutaneous coronary intervention. ACS: acute coronary syndrome;

R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R

Cardiovascular Epidemiology and Epidemiological Modelling

Proposed future revascularisation strategy in patients with ESRD based on our current results and previous guideline recommendations. Proposed future revascularisation.

Study flow chart and diagnosis at discharge from ED

Presentation transcript:

Peninsula Health Heart Service is proud to present Healthy Hearts GP Education Series 2017 - Meeting 2 Spotlight on Acute Coronary Syndromes, Stable Coronary Disease & Anti- Platelet Agents Dr Phillip Carrillo - Director of Peninsula Health Heart Service Dr Jamie Layland - Cardiologist Dr Rob Lew - Cardiologist At the end of this session participants will be able to; recall the key characteristics of NSTEMI and unstable angina. identify the most appropriate referral pathway for a patient experiencing unstable angina. recall the indications for angiography. discuss the differences in treatment approaches between stents and CABGS identify the appropriate times to commence and cease anti-platelet therapy. This is the second in a series of events planned by the Peninsula Health Heart Service. GP’s are welcome to attend any or all of the sessions. When: Tuesday 1st August 2017- 7:00pm- 9:30pm Where: Frankston Hospital Academic Centre -Level 3- Enter via main reception RSVP: Call Jennifer on 9784 2651 to register your interest or RSVP to jsidwell@phcn.vic.gov.au RACGP accredited activity 104144